2000
DOI: 10.3171/jns.2000.92.1.0121
|View full text |Cite
|
Sign up to set email alerts
|

Increased cerebral blood flow but no reversal or prevention of vasospasm in response to l-arginine infusion after subarachnoid hemorrhage

Abstract: Brief intracarotid and continuous intravenous infusion of L-arginine did not influence the incidence or degree of cerebral vasospasm. After SAH, intracarotid infusion of L-arginine markedly increased rCBF in a primate model of SAH. These findings discourage the use of L-arginine as a treatment for vasospasm after SAH.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0

Year Published

2001
2001
2013
2013

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 64 publications
(112 reference statements)
1
25
0
Order By: Relevance
“…Cerebral blood flow measurements in rabbits revealed resolution of vasospasm after SAH with short-term intracisternal and intracarotid L-arginine infusion (Ozü m et al, 2007). On the other hand, in cynomolgus monkeys, brief intracarotid and continuous intravenous infusion of L-arginine did not influence the incidence or degree of 84 cerebral vasospasm after SAH (Pluta et al, 2000). Whether the discrepancy in effectiveness of L-arginine is due to differences in animal species, route of drug administration, or dosage has not been determined.…”
Section: Therapeutic Measures In Animalsmentioning
confidence: 92%
“…Cerebral blood flow measurements in rabbits revealed resolution of vasospasm after SAH with short-term intracisternal and intracarotid L-arginine infusion (Ozü m et al, 2007). On the other hand, in cynomolgus monkeys, brief intracarotid and continuous intravenous infusion of L-arginine did not influence the incidence or degree of 84 cerebral vasospasm after SAH (Pluta et al, 2000). Whether the discrepancy in effectiveness of L-arginine is due to differences in animal species, route of drug administration, or dosage has not been determined.…”
Section: Therapeutic Measures In Animalsmentioning
confidence: 92%
“…7 Similarly, IA infusion of L-arginine has been shown to markedly increase CBF in a primate model of SAH, despite the lack of any angiographic changes. 20 Changes in perfusion at the microvasculature level probably account for this clinicoangiographic dissociation. Therefore, assessment of cerebral perfusion as opposed to angiographic results alone should be considered when evaluating novel therapies for vasospasm.…”
Section: Discussionmentioning
confidence: 99%
“…Infusion of the NO precursor L-arginine or NO donors were shown to increase CBF after experimental stroke 52,53 ; however, so far, none of these promising approaches could be translated into the clinic because of various reasons. 54 Some approaches impaired the endogenous NO production, 55 whereas others lacked a clinically feasible mode of administration 56 or, most importantly, caused significant reduction of systemic blood pressure, eg, L-arginine infusion. 57 As compared to previous attempts that tried to utilize NO-based strategies for the treatment of tissue ischemia, the main advantages of iNO are its specific effect on hypoperfused tissue without any effect on systemic blood pressure, its immediate action, simple and well-investigated route of administration, its efficacy across species, and its excellent safety profile that is based on the use of iNO in several thousand patients with pulmonary disorders.…”
Section: Discussionmentioning
confidence: 99%